These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 10196377)

  • 1. Identical mutation in patients with limb girdle muscular dystrophy type 2B or Miyoshi myopathy suggests a role for modifier gene(s).
    Weiler T; Bashir R; Anderson LV; Davison K; Moss JA; Britton S; Nylen E; Keers S; Vafiadaki E; Greenberg CR; Bushby CR; Wrogemann K
    Hum Mol Genet; 1999 May; 8(5):871-7. PubMed ID: 10196377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysferlin protein analysis in limb-girdle muscular dystrophies.
    Vainzof M; Anderson LV; McNally EM; Davis DB; Faulkner G; Valle G; Moreira ES; Pavanello RC; Passos-Bueno MR; Zatz M
    J Mol Neurosci; 2001 Aug; 17(1):71-80. PubMed ID: 11665864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identical dysferlin mutation in limb-girdle muscular dystrophy type 2B and distal myopathy.
    Illarioshkin SN; Ivanova-Smolenskaya IA; Greenberg CR; Nylen E; Sukhorukov VS; Poleshchuk VV; Markova ED; Wrogemann K
    Neurology; 2000 Dec; 55(12):1931-3. PubMed ID: 11134403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new dysferlin gene mutation in two Japanese families with limb-girdle muscular dystrophy 2B and Miyoshi myopathy.
    Ueyama H; Kumamoto T; Nagao S; Masuda T; Horinouchi H; Fujimoto S; Tsuda T
    Neuromuscul Disord; 2001 Mar; 11(2):139-45. PubMed ID: 11257469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysferlin homozygous mutation G1418D causes limb-girdle type 2B in a Mexican family.
    Rosas-Vargas H; Gómez-Díaz B; Ruano-Calderón L; Fernández-Valverde F; Roque-Ramírez B; Portillo-Bobadilla T; Ordoñez-Razo RM; Minauro-Sanmiguel F; Coral-Vázquez R
    Genet Test; 2007; 11(4):391-6. PubMed ID: 18294055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein and gene analyses of dysferlinopathy in a large group of Japanese muscular dystrophy patients.
    Tagawa K; Ogawa M; Kawabe K; Yamanaka G; Matsumura T; Goto K; Nonaka I; Nishino I; Hayashi YK
    J Neurol Sci; 2003 Jul; 211(1-2):23-8. PubMed ID: 12767493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysferlin mutation analysis in a group of Italian patients with limb-girdle muscular dystrophy and Miyoshi myopathy.
    Kawabe K; Goto K; Nishino I; Angelini C; Hayashi YK
    Eur J Neurol; 2004 Oct; 11(10):657-61. PubMed ID: 15469449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracellular accumulation and reduced sarcolemmal expression of dysferlin in limb--girdle muscular dystrophies.
    Piccolo F; Moore SA; Ford GC; Campbell KP
    Ann Neurol; 2000 Dec; 48(6):902-12. PubMed ID: 11117547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular analysis of LGMD-2B and MM patients: identification of novel DYSF mutations and possible founder effect in the Italian population.
    Cagliani R; Fortunato F; Giorda R; Rodolico C; Bonaglia MC; Sironi M; D'Angelo MG; Prelle A; Locatelli F; Toscano A; Bresolin N; Comi GP
    Neuromuscul Disord; 2003 Dec; 13(10):788-95. PubMed ID: 14678801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The sarcolemmal proteins dysferlin and caveolin-3 interact in skeletal muscle.
    Matsuda C; Hayashi YK; Ogawa M; Aoki M; Murayama K; Nishino I; Nonaka I; Arahata K; Brown RH
    Hum Mol Genet; 2001 Aug; 10(17):1761-6. PubMed ID: 11532985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel sequence variants in dysferlin-deficient muscular dystrophy leading to mRNA decay and possible C2-domain misfolding.
    Wenzel K; Carl M; Perrot A; Zabojszcza J; Assadi M; Ebeling M; Geier C; Robinson PN; Kress W; Osterziel KJ; Spuler S
    Hum Mutat; 2006 Jun; 27(6):599-600. PubMed ID: 16705711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variable reduction of caveolin-3 in patients with LGMD2B/MM.
    Walter MC; Braun C; Vorgerd M; Poppe M; Thirion C; Schmidt C; Schreiber H; Knirsch UI; Brummer D; Müller-Felber W; Pongratz D; Müller-Höcker J; Huebner A; Lochmüller H
    J Neurol; 2003 Dec; 250(12):1431-8. PubMed ID: 14673575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mutational and clinical features of Japanese patients with dysferlinopathy (Miyoshi myopathy and limb girdle muscular dystrophy type 2B)].
    Aoki M; Takahashi T
    Rinsho Shinkeigaku; 2005 Nov; 45(11):938-42. PubMed ID: 16447768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysferlin is a plasma membrane protein and is expressed early in human development.
    Anderson LV; Davison K; Moss JA; Young C; Cullen MJ; Walsh J; Johnson MA; Bashir R; Britton S; Keers S; Argov Z; Mahjneh I; Fougerousse F; Beckmann JS; Bushby KM
    Hum Mol Genet; 1999 May; 8(5):855-61. PubMed ID: 10196375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DYSF mutation analysis in a group of Chinese patients with dysferlinopathy.
    Zhao Z; Hu J; Sakiyama Y; Okamoto Y; Higuchi I; Li N; Shen H; Takashima H
    Clin Neurol Neurosurg; 2013 Aug; 115(8):1234-7. PubMed ID: 23254335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Painful enlargement of the calf muscles in limb girdle muscular dystrophy type 2B (LGMD2B) with a novel compound heterozygous mutation in DYSF.
    Diers A; Carl M; Stoltenburg-Didinger G; Vorgerd M; Spuler S
    Neuromuscul Disord; 2007 Feb; 17(2):157-62. PubMed ID: 17129727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy.
    Liu J; Aoki M; Illa I; Wu C; Fardeau M; Angelini C; Serrano C; Urtizberea JA; Hentati F; Hamida MB; Bohlega S; Culper EJ; Amato AA; Bossie K; Oeltjen J; Bejaoui K; McKenna-Yasek D; Hosler BA; Schurr E; Arahata K; de Jong PJ; Brown RH
    Nat Genet; 1998 Sep; 20(1):31-6. PubMed ID: 9731526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a novel founder mutation in the DYSF gene causing clinical variability in the Spanish population.
    Vilchez JJ; Gallano P; Gallardo E; Lasa A; Rojas-García R; Freixas A; De Luna N; Calafell F; Sevilla T; Mayordomo F; Baiget M; Illa I
    Arch Neurol; 2005 Aug; 62(8):1256-9. PubMed ID: 16087766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Splicing mutation in dysferlin produces limb-girdle muscular dystrophy with inflammation.
    McNally EM; Ly CT; Rosenmann H; Mitrani Rosenbaum S; Jiang W; Anderson LV; Soffer D; Argov Z
    Am J Med Genet; 2000 Apr; 91(4):305-12. PubMed ID: 10766988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case report of an adolescent girl with limb-girdle muscular dystrophy type 2B - the usefulness of muscle protein immunostaining in the diagnosis of dysferlinopathies.
    Szymanska S; Rokicki D; Karkucinska-Wieckowska A; Szymanska-Debinska T; Ciara E; Ploski R; Grajkowska W; Pronicki M
    Folia Neuropathol; 2014; 52(4):452-6. PubMed ID: 25574751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.